Debora Fumagalli
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.
Journal: ESMO open
Published: March 11, 2022
Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy.
Journal: Journal of the National Cancer Institute
Published: February 06, 2022
Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 28, 2021
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 15, 2021
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
Journal: The New England journal of medicine
Published: June 03, 2021
Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 30, 2021
Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 15, 2021
Immune Checkpoint Blockade in HER2-Positive Breast Cancer: What Role in Early Disease Setting?
Journal: Cancers
Published: March 08, 2021
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 04, 2021
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
Journal: Cancer discovery
Published: November 11, 2020
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 26, 2020
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Journal: The Lancet. Oncology
Published: October 13, 2020
Last Updated: 09/26/2026